Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseBiomarkers of Alzheimer's diseaseExpanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted ApproachesFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsMeta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic CriteriaPlatelets and Alzheimer's disease: Potential of APP as a biomarkerClinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkersPrediction of cognitive decline in healthy older adults using fMRIFunctional magnetic resonance imaging of semantic memory as a presymptomatic biomarker of Alzheimer's disease riskGWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.PET amyloid-beta imaging in preclinical Alzheimer's diseaseBiomarkers for cognitive impairment and dementia in elderly people.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.CSF biomarkers for mild cognitive impairment.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.The role of biomarkers in clinical trials for Alzheimer diseaseBiomarkers in the diagnosis of Alzheimer's disease: are we ready?Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Biomarkers in translational research of Alzheimer's diseaseTotal and phosphorylated tau protein as biological markers of Alzheimer's disease.Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer's disease and other dementias.The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease.Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.Cerebrospinal fluid biomarkers in mild cognitive impairment and dementiaBiological markers and Alzheimer disease: a canadian perspectiveQualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometryCerebrospinal fluid biomarkers for dementia with lewy bodies.Hyperphosphorylation and cleavage at D421 enhance tau secretionThe diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.Probable early-onset Alzheimer's disease in an apolipoprotein E2 homozygoteImaging and biomarkers in early Alzheimer's disease and mild cognitive impairment.Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic targetBiomarkers of the dementia.Biomarkers predicting Alzheimer's disease in cognitively normal aging.Bridging molecular genetics and biomarkers in lewy body and related disordersBiomarkers in Alzheimer's disease.Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.
P2860
Q22252572-0C4D1B7B-539C-40CD-9C64-403BCF94509BQ24650667-57D1F3F8-29BF-4E0B-8CA2-C7B1B5C0CCF6Q26770708-7CFCF5DB-986D-469B-B9A2-FA5CFEDBBF76Q26784569-9F23FF7B-D9B7-48DC-BA17-E28E66F88B2FQ26864063-10C1F7EF-2CC6-486A-A6A0-914C1E910F09Q27001550-A633DACA-A4FA-4003-A5FA-A6EA278C4784Q27008249-22840EE6-992E-4F5A-97BA-0CAF10E99373Q28383378-406AAF32-E40D-4E50-B74C-55D12A96E550Q28394799-C8C379E6-02B1-4B3A-888D-C07D9FDAF0F1Q29417137-D5BA930E-6CEA-4309-BC87-77E98CDBD29EQ30040695-891773B6-0AE8-4AEC-AC59-BA6ADD93D7D8Q30370745-3F3B87C8-340E-4BAC-926E-868683E1DEEDQ30845482-ED8616BD-8436-432B-80DF-18EBA73D1A29Q30953185-828F02DB-D2BA-4898-8589-F37B41DBCDF8Q30996799-89C09DCF-E17D-4298-AD33-41D1C015B8D9Q31032781-C7B17575-2599-4870-B58F-A527DE025BB7Q31050728-91CC001B-69C3-4F3F-8E22-D300C7CA5F05Q31146512-804526CE-CC41-48A0-A0FD-7BDB1D5288A4Q33223171-B85233D7-1DB2-4B9F-B738-F087FB2F1299Q33556189-A47F2D84-5F6A-4611-B815-374C278231CFQ33624674-83B1C7BF-5F88-4093-98AC-0B3D46D8600AQ33821194-A7553E4B-6C2D-4617-95DC-E16A8EF6F323Q33841363-449D5903-F6BE-4000-B0BD-078E8C92564CQ33924646-626598D8-3B55-405C-9089-F9301DEE71D3Q33936708-228AA2A4-2C06-4490-AA41-EC5718E09EC3Q34089784-133FE908-FDDC-40E9-AB74-D211F886328AQ34157882-42035A79-529D-4012-9B7F-295DA8E3F5B1Q34248241-DD96F412-6B04-4C56-9EBE-E955C568BCEBQ34277477-641E281D-DA4B-48D7-8064-198C4D3F7A38Q34296479-F93E53C7-1AEF-47FA-8F20-92B2647CA943Q34354478-EA711AD5-04D7-486D-B17C-C65689FD845CQ34992846-F42BCD96-3DE6-462B-A1A3-7C8C0E40700DQ35014708-E8A691D2-C3A1-401B-A25D-F1B5B9E8CAA4Q35016882-45D14C6B-078C-4BA1-A846-EA261DBD683EQ35030049-25BD502A-0B0C-48AA-8676-B20337B0B081Q35091673-1609CEAF-66AE-4522-83E0-CEC75DA8D8D5Q35094391-48BEDBF5-E738-4BA4-9CD2-3806F4B82C1CQ35113795-E61C0D65-3D0C-46AF-BE97-BC661D31BEDCQ35126030-E737596C-A0C4-42A3-8998-A5658625D1C0Q35236838-BBADF6FB-F1B0-4D99-BC60-16FB27ECC61C
P2860
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@ast
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@en
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@nl
type
label
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@ast
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@en
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@nl
prefLabel
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@ast
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@en
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@nl
P2093
P50
P921
P356
P1433
P1476
Measurement of phosphorylated ...... ive cerebrospinal fluid study.
@en
P2093
Alexander Goernitz
Cheryl McCulloch
Daniel Kerkman
Hideto Ohno
Hugo Vanderstichele
John DeBernardis
Katharina Buerger
Koichi Ishiguro
Magnus Sjoegren
Niels Andreasen
P304
P356
10.1001/ARCHPSYC.61.1.95
P407
P577
2004-01-01T00:00:00Z